Certolizumab Pegol Effectiveness and Retention Rate in Psoriatic Arthritis. Real Life Data

被引：0
|
作者：
Conesa, Arantxa [1 ]
Fernandez, Manuel [2 ]
Exposito, Rosa [3 ]
Campos, Jose [4 ]
Ramon Lamua, Jose [5 ]
del Pilar Navarro, Maria [6 ]
Rubio-Munoz, Paula [7 ]
Ahijado-Guzman, Pilar [8 ]
Gonzalez, Carlos M. [9 ]
机构：
[1] Hosp Clin Univ Valencia, Valencia, Spain
[2] Hosp Univ Guadalajara, Guadalajara, Spain
[3] Hosp Comarcal Laredo, Rheumatol, Laredo, Spain
[4] Hosp Univ Puerta de Hierro Majadahonda, Rheumatol, Madrid, Spain
[5] Hosp Henares, Madrid, Spain
[6] Hosp Fuenlabrada, Fuenlabrada, Spain
[7] Hosp Univ Germans & Trias Pujol, Rheumatol, Badalona, Spain
[8] Fuenlabradas Hosp, Rheumatol Unit, Madrid, Madrid, Spain
[9] Hosp Gen Univ Gregorio Maranon, Rheumatol, Madrid, Spain
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1518
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Certolizumab pegol for the treatment of psoriatic arthritis (vol 11, pg 307, 2015)
    Hansen, R. B.
    Kavanaugh, A.
    Expert Review of Clinical Immunology, 2015, 11 (05) : 689 - 689
  • [32] Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE)
    Florenzo Iannone
    Leonardo Santo
    Romano Bucci
    Angelo Semeraro
    Giorgio Carlino
    Franco Paoletti
    Laura Quarta
    Pierfrancesco Leucci
    Carmelo Zuccaro
    Antonio Marsico
    Crescenzio Scioscia
    Francesca D’Onofrio
    Daniela Mazzotta
    Maurizio Muratore
    Francesco Paolo Cantatore
    Giovanni Lapadula
    Clinical Rheumatology, 2018, 37 : 667 - 675
  • [33] Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE)
    Iannone, Florenzo
    Santo, Leonardo
    Bucci, Romano
    Semeraro, Angelo
    Carlino, Giorgio
    Paoletti, Franco
    Quarta, Laura
    Leucci, Pierfrancesco
    Zuccaro, Carmelo
    Marsico, Antonio
    Scioscia, Crescenzio
    D'Onofrio, Francesca
    Mazzotta, Daniela
    Muratore, Maurizio
    Cantatore, Francesco Paolo
    Lapadula, Giovanni
    CLINICAL RHEUMATOLOGY, 2018, 37 (03) : 667 - 675
  • [34] Nail Psoriasis Treated With Certolizumab Pegol in Patients With Psoriatic Arthritis: Preliminary Observation
    Mazzeo, M.
    Dattola, A.
    Cannizzaro, M. V.
    Bianchi, L.
    ACTAS DERMO-SIFILIOGRAFICAS, 2019, 110 (02): : 169 - 171
  • [35] Certolizumab Pegol: A Review of Its Use in Patients with Axial Spondyloarthritis or Psoriatic Arthritis
    Dhillon, Sohita
    DRUGS, 2014, 74 (09) : 999 - 1016
  • [36] FIRST REAL LIFE EXPERIENCE WITH CERTOLIZUMAB PEGOL IN RHEUMATHOID ARTHRITIS (RA) IN LATIN-AMERICA
    Guzman, R.
    Roa, G.
    Rodriguez, W.
    Cordoba, J.
    Villalba, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 873 - 873
  • [37] CLINICAL EFFECTIVENESS OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF RHEUMATOID ARTHRITIS: A MULTICENTRE STUDY
    Isaacs, Anthony
    Abraham, Sonya
    RHEUMATOLOGY, 2014, 53 : 109 - 109
  • [38] Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis
    Nozaki, Yuji
    Hidaka, Toshihiko
    Ri, Jinhai
    Itami, Tetsu
    Tomita, Daisuke
    Okada, Akinori
    Ashida, Chisato
    Ikeda, Fusayo
    Yamamoto, Atsuhiro
    Funahashi, Keiko
    Kinoshita, Koji
    Matsubara, Tsukasa
    Funauchi, Masanori
    Matsumura, Itaru
    FRONTIERS IN MEDICINE, 2021, 8
  • [39] Correction to: Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE)
    Florenzo Iannone
    Leonardo Santo
    Romano Bucci
    Angelo Semeraro
    Giorgio Carlino
    Franco Paoletti
    Laura Quarta
    Pierfrancesco Leucci
    Carmelo Zuccaro
    Antonio Marsico
    Crescenzio Scioscia
    Francesca D’Onofrio
    Daniela Mazzotta
    Maurizio Muratore
    Francesco Paolo Cantatore
    Giovanni Lapadula
    Clinical Rheumatology, 2018, 37 : 1141 - 1142
  • [40] Effect of certolizumab pegol on dermatologic outcomes over 96 weeks in patients with psoriatic arthritis
    Mease, Philip
    Hoepken, Bengt
    Davies, Owen
    Arledge, Terri
    Peterson, Luke
    van der Heijde, Desiree
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB232 - AB232
12345